WBA250117P22500
- 13.21
- 0.000.00%
Walgreens Boots Alliance Newsroom
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Quanterix (QTRX) and Walgreens Boots Alliance (WBA)
Express News | Walgreens : RBC Raises Target Price to $12 From $9
Walgreens Boots Alliance Options Spot-On: On January 14th, 121.45K Contracts Were Traded, With 1.07 Million Open Interest
On January 14th ET, $Walgreens Boots Alliance(WBA.US)$ had active options trading, with a total trading volume of 121.45K options for the day, of which put options accounted for 26.22% of the total
A Quick Look at Today's Ratings for Walgreens Boots Alliance(WBA.US), With a Forecast Between $7 to $15
Walgreens Boots Alliance Options Spot-On: On January 13th, 143.87K Contracts Were Traded, With 1.08 Million Open Interest
On January 13th ET, $Walgreens Boots Alliance(WBA.US)$ had active options trading, with a total trading volume of 143.87K options for the day, of which put options accounted for 34.38% of the total
Jefferies Adjusts Walgreens Boots Alliance Price Target to $11 From $9
TD Cowen Adjusts Price Target on Walgreens Boots Alliance to $15 From $14
Evercore ISI Group Maintains In-Line on Walgreens Boots Alliance, Raises Price Target to $12
Jim Cramer: Walgreens' (WBA) Plan to Close Stores and Cut Costs – A Path to Recovery?
Walgreens Boots Alliance Is Maintained at Underperform by B of A Securities
Walgreens Boots Alliance Analyst Ratings
Truist Financial Sticks to Its Hold Rating for Walgreens Boots Alliance (WBA)
BofA Securities Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Raises Target Price to $8.5
Express News | Walgreens Boots Alliance : Deutsche Bank Raises Target Price to $11 From $10
Challenges in Profitability and Financial Flexibility Lead to Sell Rating on Walgreens Boots Alliance
Express News | RPT-Buzz-US Stocks Weekly: Seesaw
U.S. Stock Market Insights | Delta Air Lines has scored big! Stock prices hit a new high, with performance and outlook both exceeding expectations; a $16.4 billion acquisition of Calpine, Energy giant CEG surged by 25.16%.
The Medical merger and acquisition frenzy has started again! It is rumored that Johnson & Johnson is in talks to acquire the biopharmaceutical company Intra-Cellular Therapies Inc., which focuses on treating central nervous system diseases, and its stock price has soared nearly 15%.
Dow Tumbles Around 700 Points Following Jobs Data, Investor Sentiment Dips Further: Greed Index Remains In 'Fear' Zone
Daily Options Tracking | The high-performing stock WBA surged nearly 30% last Friday, with a call option expiring this Friday netting over 5 times profit; Tesla's Put ratio rose to 45%, with large investors spending tens of millions of dollars on bullish
NVIDIA fell over 3% in the previous trading day, with the Options Chain volume increasing to 4.15 million contracts, of which Put options accounted for 40.8%; on the Options Chain, the call option with a strike price of 140 dollars expiring this Friday had the highest volume of 0.236 million contracts, with an open interest of 0.251 million contracts.
Trump's 'economic strategist' advocates for raising tariffs to 20%-50%, abandoning a strong dollar, and forcing the Federal Reserve into quantitative easing.
Stephen Miran, the chairman of the Council of Economic Advisers nominated by Trump, put forward his economic theory. He advocates for high tariffs, a weak dollar, and Federal Reserve quantitative easing.